Medication initiation burden required to comply with heart failure guideline recommendations and hospital quality measures

Circulation

Volumn 132, Issue 14, 2015, Pages 1347-1353

  Allen, Larry A ^a   Fonarow, Gregg C ^b   Liang, Li ^c   Schulte, Phillip J ^c   Masoudi, Frederick A ^a   Rumsfeld, John S ^a,d   Ho, P Michael ^a,d   Eapen, Zubin J ^c   Hernandez, Adrian F ^c   Heidenreich, Paul A ^e   Bhatt, Deepak L ^f   Peterson, Eric D ^c   Krumholz, Harlan M ^g,h  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b UCLA MEDICAL CENTER   (United States)

^c DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

^e VA PALO ALTO HEALTH CARE SYSTEM   (United States)

^f HARVARD MEDICAL SCHOOL   (United States)

^g ROBERT WOOD JOHNSON FOUNDATION   (United States)

^h YALE NEW HAVEN HOSPITAL   (United States)

Author keywords

heart failure; medication adherence; medication therapy management; prescribing patterns, physician; quality of health care

Indexed keywords

ALDOSTERONE ANTAGONIST; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTICOAGULANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDRALAZINE; ISOSORBIDE DINITRATE; CARDIOVASCULAR AGENT;

ADULT; AGED; ANEMIA; ARTICLE; COMORBIDITY; CROSS-SECTIONAL STUDY; DEPRESSION; DIALYSIS; DRUG CONTRAINDICATION; DRUG INDICATION; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HOSPITAL ADMISSION; HUMAN; HYPERLIPIDEMIA; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; ISCHEMIC HEART DISEASE; KIDNEY FAILURE; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MEDICARE; MEDICATION COMPLIANCE; MEDICATION THERAPY MANAGEMENT; PACEMAKER; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; SMOKING; BODY MASS; CLASSIFICATION; CONTRAINDICATIONS; DRUG COMBINATION; DRUG HYPERSENSITIVITY; DRUG SUBSTITUTION; DRUG UTILIZATION; EVIDENCE BASED MEDICINE; HEALTH CARE QUALITY; HOSPITAL; HOSPITAL DISCHARGE; MIDDLE AGED; POLYPHARMACY; STANDARDS; STATISTICS AND NUMERICAL DATA; VERY ELDERLY;

AGED; AGED, 80 AND OVER; BODY MASS INDEX; CARDIOVASCULAR AGENTS; COMORBIDITY; CROSS-SECTIONAL STUDIES; DRUG HYPERSENSITIVITY; DRUG PRESCRIPTIONS; DRUG SUBSTITUTION; DRUG THERAPY, COMBINATION; DRUG UTILIZATION; EVIDENCE-BASED MEDICINE; FEMALE; GUIDELINE ADHERENCE; HEART FAILURE; HOSPITALS; HUMANS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; PATIENT ADMISSION; PATIENT DISCHARGE; POLYPHARMACY; PRACTICE GUIDELINES AS TOPIC; QUALITY ASSURANCE, HEALTH CARE;

EID: 84943408986     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.115.014281     Document Type: Article

References (25)

1. Fonarow GC, Abraham WT, Albert NM, Stough WG, Gheorghiade M, Greenberg BH, O'Connor CM, Pieper K, Sun JL, Yancy C, Young JB, OPTIMIZE-HF Investigators and Hospitals Association between performance measures and clinical outcomes for patients hospitalized with heart failure. JAMA 2007 297 61 70. doi: 10.1001/jama.297.1.61
2. Hernandez AF, Hammill BG, O'Connor CM, Schulman KA, Curtis LH, Fonarow GC., Clinical effectiveness of beta-blockers in heart failure: findings from the OPTIMIZE-HF (Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure) Registry. J Am Coll Cardiol 2009 53 184 192. doi: 10.1016/j.jacc.2008.09.031
3. Gattis WA, O'Connor CM, Gallup DS, Hasselblad V, Gheorghiade M, IMPACT-HF Investigators and Coordinators Predischarge initiation of carvedilol in patients hospitalized for decompensated heart failure: results of the Initiation Management Predischarge: Process for Assessment of Carvedilol Therapy in Heart Failure (IMPACT-HF) trial. J Am Coll Cardiol 2004 43 1534 1541. doi: 10.1016/j.jacc.2003.12.040
4. Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE Jr, Drazner MH, Fonarow GC, Geraci SA, Horwich T, Januzzi JL, Johnson MR, Kasper EK, Levy WC, Masoudi FA, McBride PE, McMurray JJ, Mitchell JE, Peterson PN, Riegel B, Sam F, Stevenson LW, Tang WH, Tsai EJ, Wilkoff BL, WRITING COMMITTEE MEMBERS; American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 2013 128 e240 e327. doi: 10.1161/CIR.0b013e31829e8776
5. Bonow RO, Ganiats TG, Beam CT, Blake K, Casey DE Jr, Goodlin SJ, Grady KL, Hundley RF, Jessup M, Lynn TE, Masoudi FA, Nilasena D, Piña IL, Rockswold PD, Sadwin LB, Sikkema JD, Sincak CA, Spertus J, Torcson PJ, Torres E, Williams MV, Wong JB, American College of Cardiology Foundation; American Heart Association Task Force on Performance Measures; American Medical Association-Physician Consortium for Performance Improvement ACCF/AHA/AMA-PCPI 2011 performance measures for adults with heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Performance Measures and the American Medical Association-Physician Consortium for Performance Improvement. Circulation 2012 125 2382 2401. doi: 10.1161/CIR.0b013e3182507bec
6. Spivack SB, Bernheim SM, Forman HP, Drye EE, Krumholz HM., Hospital cardiovascular outcome measures in federal pay-for-reporting and pay-for-performance programs: a brief overview of current efforts. Circ Cardiovasc Qual Outcomes 2014 7 627 633. doi: 10.1161/CIRCOUTCOMES.114.001364
7. Zullig LL, Peterson ED, Bosworth HB., Ingredients of successful interventions to improve medication adherence. JAMA 2013 310 2611 2612. doi: 10.1001/jama.2013.282818
8. Krumholz HM., Post-hospital syndrome: an acquired, transient condition of generalized risk. N Engl J Med 2013 368 100 102. doi: 10.1056/NEJMp1212324
9. Fonarow GC, Abraham WT, Albert NM, Gattis WA, Gheorghiade M, Greenberg B, O'Connor CM, Yancy CW, Young J., Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF): rationale and design. Am Heart J 2004 148 43 51. doi: 10.1016/j.ahj.2004.03.004
10. LaBresh KA, Ellrodt AG, Gliklich R, Liljestrand J, Peto R., Get With The Guidelines for cardiovascular secondary prevention: pilot results. Arch Intern Med 2004 164 203 209. doi: 10.1001/archinte.164.2.203
11. Smaha LA, American Heart Association The American Heart Association Get With The Guidelines program. Am Heart J 2004 148 suppl S46 S48. doi: 10.1016/j.ahj.2004.09.015
12. Fonarow GC., Epidemiology and risk stratification in acute heart failure. Am Heart J 2008 155 200 207. doi: 10.1016/j.ahj.2006.10.043
13. Albert NM, Yancy CW, Liang L, Zhao X, Hernandez AF, Peterson ED, Cannon CP, Fonarow GC., Use of aldosterone antagonists in heart failure. JAMA 2009 302 1658 1665. doi: 10.1001/jama.2009.1493
14. Eapen ZJ, Grau-Sepulveda MV, Fonarow GC, Heidenreich PA, Peterson ED, Hernandez AF., Prescribing warfarin at discharge for heart failure patients: findings from the Get With The Guidelines-Heart Failure Registry. Int J Cardiol 2014 172 e322 e323. doi: 10.1016/j.ijcard.2013.12.161
15. Eapen ZJ, Mi X, Qualls LG, Hammill BG, Fonarow GC, Turakhia MP, Heidenreich PA, Peterson ED, Curtis LH, Hernandez AF, Al-Khatib SM., Adherence and persistence in the use of warfarin after hospital discharge among patients with heart failure and atrial fibrillation. J Card Fail 2014 20 23 30. doi: 10.1016/j.cardfail.2013.11.006
16. Allen LA, Magid DJ, Zeng C, Peterson PN, Clarke CL, Shetterly S, Brand DW, Masoudi FA., Patterns of beta-blocker intensification in ambulatory heart failure patients and short-Term association with hospitalization. BMC Cardiovasc Disord 2012 12 43. doi: 10.1186/1471-2261-12-43
17. Hernandez AF, Greiner MA, Fonarow GC, Hammill BG, Heidenreich PA, Yancy CW, Peterson ED, Curtis LH., Relationship between early physician follow-up and 30-day readmission among Medicare beneficiaries hospitalized for heart failure. JAMA 2010 303 1716 1722. doi: 10.1001/jama.2010.533
18. Kolandaivelu K, Leiden BB, O'Gara PT, Bhatt DL., Non-Adherence to cardiovascular medications. Eur Heart J 2014 35 3267 3276. doi: 10.1093/eurheartj/ehu364
19. Jackevicius CA, Li P, Tu JV., Prevalence, predictors, and outcomes of primary nonadherence after acute myocardial infarction. Circulation 2008 117 1028 1036. doi: 10.1161/CIRCULATIONAHA.107.706820
20. Lamb DA, Eurich DT, McAlister FA, Tsuyuki RT, Semchuk WM, Wilson TW, Blackburn DF., Changes in adherence to evidence-based medications in the first year after initial hospitalization for heart failure: observational cohort study from 1994 to 2003. Circ Cardiovasc Qual Outcomes 2009 2 228 235. doi: 10.1161/CIRCOUTCOMES.108.813600
21. Ho PM, Tsai TT, Maddox TM, Powers JD, Carroll NM, Jackevicius C, Go AS, Margolis KL, DeFor TA, Rumsfeld JS, Magid DJ., Delays in filling clopidogrel prescription after hospital discharge and adverse outcomes after drug-eluting stent implantation: implications for transitions of care. Circ Cardiovasc Qual Outcomes 2010 3 261 266. doi: 10.1161/CIRCOUTCOMES.109.902031
22. Steinman MA, Dimaano L, Peterson CA, Heidenreich PA, Knight SJ, Fung KZ, Kaboli PJ., Reasons for not prescribing guideline-recommended medications to adults with heart failure. Med Care 2013 51 901 907. doi: 10.1097/MLR.0b013e3182a3e525
23. Calvin JE, Shanbhag S, Avery E, Kane J, Richardson D, Powell L., Adherence to evidence-based guidelines for heart failure in physicians and their patients: lessons from the Heart Failure Adherence Retention Trial (HART). Congest Heart Fail 2012 18 73 78. doi: 10.1111/j.1751-7133.2011.00263.x.
24. Feltner C, Jones CD, Cené CW, Zheng ZJ, Sueta CA, Coker-Schwimmer EJ, Arvanitis M, Lohr KN, Middleton JC, Jonas DE., Transitional care interventions to prevent readmissions for persons with heart failure: a systematic review and meta-Analysis. Ann Intern Med 2014 160 774 784. doi: 10.7326/M14-0083
25. Luttik ML, Jaarsma T, van Geel PP, Brons M, Hillege HL, Hoes AW, de Jong R, Linssen G, Lok DJ, Berge M, van Veldhuisen DJ., Long-Term follow-up in optimally treated and stable heart failure patients: primary care vs. heart failure clinic. Results of the COACH-2 study. Eur J Heart Fail 2014 16 1241 1248. doi: 10.1002/ejhf.173